Phenotypic Predictors of Response to Simvastatin Therapy Among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) Study
- 1 March 2006
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (6) , 843-850
- https://doi.org/10.1016/j.amjcard.2005.09.134
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Smoking Diminishes the Beneficial Effect of Statins: Observations from the Landmark TrialsAngiology, 2001
- Benefits of Pravastatin on Cardiovascular Events and Mortality in Older Patients with Coronary Heart Disease Are Equal to or Exceed Those Seen in Younger Patients: Results from the LIPID TrialAnnals of Internal Medicine, 2001
- Efficacy and Safety of Cerivastatin, 0.2 mg and 0.4 mg, in Patients with Primary Hypercholesterolemia: a Multinational, Randomised, Double-blind StudyCurrent Medical Research and Opinion, 1999
- Effect of Pravastatin on Cardiovascular Events in Older Patients with Myocardial Infarction and Cholesterol Levels in the Average Range: Results of the Cholesterol and Recurrent Events (CARE) TrialAnnals of Internal Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Relation of Smoking and Alcohol Consumption to Serum Fatty AcidsAmerican Journal of Epidemiology, 1996
- Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.Circulation, 1992
- Efficacy and tolerability of lovastatin in a six-month study: Analysis by gender, age and hypertensive statusThe American Journal of Cardiology, 1990
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972